Boehringer Ingelheim Chooses Docuvera® Structured Content Management to Drive Efficiency in Pharmaceutical Documentation
Summary
Docuvera gives Boehringer Ingelheim a powerful, yet intuitive platform for authors to create and update pharmaceutical documentation in a fraction of the time versus traditional desktop software. Docuvera, developed specifically for the Life Sciences market, combines component authoring, review and approval, publishing, and audit trails on a single platform allowing BioPharmas to collaboratively author documents, conduct targeted reviews of modified components, and publish Word, PDF or HTML documents from a single source. “With Docuvera, medical authors now have an intuitive system that feels as familiar as desktop software, but also allows them to create/update, review/approve and publish documents in a fraction of the time as traditional methods.” Docuvera is a new breed of SaaS services targeting the Life Sciences segment bringing new technology to an industry that has traditionally been underserved by advances in software. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. Through a variety of products and services, ASC serves more than 300 customers, ranging from the world’s largest pharmaceutical companies to emerging business in high tech manufacturing.
Classifications
AskAI Classifications
LabelsLinked Companies
